Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-12-05
1993-07-13
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142338, 514316, 514321, 514326, 544 61, 544129, 546193, 546197, 546207, 546214, C07D40500, C07D41700, A61K 3154, A61K 31535
Patent
active
052273792
ABSTRACT:
Piperidine compounds having the formula ##STR1## wherein R.sup.3 is 3,4-methylenedioxyphenyl, phenyl, or naphthyl which are optionally substituted with one or more halogen, C.sub.1-6 -alkoxy, or phenoxy, cyano, mono or poly halogenated C.sub.1-6 -alkyl, C.sub.2-6 -alkenyl, C.sub.1-6 -alkyl, or C.sub.3-5 -alkylene, R.sup.1 is straight or branched C.sub.1-8 -alkyl substituted with piperidinyl morpholinyl thiomorpholinyl dioxolanyl or tetrahydrofuranyl, which heterocyclic radical is unsubstituted or C.sub.1-6 -alkyl substituted,
REFERENCES:
Appel. "Current Neurology" vol. 6, Chapter 5, pp. 107-108 (1987).
Sheardown, J. J. et al., Science 247, 571-574 (1990).
Drejer Jorgen
Jakobsen Palle
Chang Celia
Hueschen Gordon W.
Ivy C. Warren
Novo Nordisk A S
LandOfFree
Piperidine compounds and their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine compounds and their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine compounds and their preparation and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2312167